Palmatine

Palmatine is an isoquinoline alkaloid found in plants like Coptis chinensis and Berberis species that exhibits cholinesterase inhibitory activity and anti-inflammatory properties. This bioactive compound works by inhibiting acetylcholinesterase enzymes and modulating inflammatory pathways in preclinical studies.

Origin & History

Palmatine is a yellow protoberberine isoquinoline alkaloid naturally occurring in plants from families like Berberidaceae and Papaveraceae. It is extracted from rhizomes, roots, stems, and stem barks using methods such as liquid chromatography and centrifugal partition chromatography.

Historical & Cultural Context

Palmatine has been used in Asian traditional medicine for conditions like jaundice, hypertension, and dysentery. Its historical application spans plants from families such as Berberidaceae and Papaveraceae.

Health Benefits

• Potential anti-inflammatory effects observed in preclinical studies.
• Exhibits cholinesterase inhibitory activity, suggesting benefits for CNS health, based on in vitro studies.
• May have antihypertensive properties as indicated by animal model research.
• Shows potential liver protective effects as part of traditional use in treating jaundice.
• Could aid in managing dysentery, supported by historical medicinal applications.

How It Works

Palmatine exerts its effects primarily through inhibition of acetylcholinesterase and butyrylcholinesterase enzymes, which increases acetylcholine availability in neural tissues. The compound also modulates inflammatory pathways by suppressing pro-inflammatory cytokines like TNF-α and IL-6. Additionally, palmatine may interact with calcium channels and demonstrate hepatoprotective effects through antioxidant mechanisms.

Scientific Research

No human clinical trials or meta-analyses specifically on palmatine are available. Research is mostly preclinical, with scattered studies in databases like PubMed and Scopus focusing on animal models or in vitro analyses.

Clinical Summary

Current evidence for palmatine comes primarily from in vitro and animal studies, with limited human clinical data available. In vitro studies have demonstrated IC50 values for acetylcholinesterase inhibition ranging from 2-15 μM depending on the source and preparation. Animal studies using doses of 10-50 mg/kg have shown potential antihypertensive effects in spontaneously hypertensive rats. The lack of robust human clinical trials limits the ability to establish definitive therapeutic benefits and optimal dosing protocols.

Nutritional Profile

Palmatine is a naturally occurring isoquinoline alkaloid (protoberberine-type), not a macronutrient or conventional food ingredient, so it lacks a traditional nutritional profile in terms of carbohydrates, fats, proteins, vitamins, or minerals. Its profile is defined entirely by its bioactive alkaloid chemistry. Molecular formula: C21H22NO4+; molecular weight: ~352.4 g/mol. Found in plant sources including Coptis japonica (0.1–1.5% dry weight of rhizome), Berberis species (co-occurring with berberine at variable concentrations of 0.05–0.8% dry weight), Phellodendron amurense bark (approximately 0.3–1.2% dry weight), and Tinospora cordifolia stems (trace to 0.2% dry weight). As an isolated compound, it contains no fiber, protein, fat, or conventional micronutrients. Bioavailability: oral bioavailability is considered low-to-moderate as with most protoberberine alkaloids; studies suggest significant first-pass hepatic metabolism and P-glycoprotein efflux limiting absorption, with Cmax typically reached within 1–3 hours in rodent pharmacokinetic models. Lipophilicity (logP approximately 2.1–2.5) allows moderate membrane permeability. It is typically encountered as a chloride or iodide salt in standardized extracts. No dietary reference intake or recommended daily allowance has been established. Concentrations in commercial herbal extracts vary widely (1–10 mg per dose depending on source plant and extraction method).

Preparation & Dosage

No clinically studied dosage ranges for palmatine in humans are available due to the absence of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Berberine, Coptisine, Jatrorrhizine, Curcumin, Ginger

Safety & Interactions

Palmatine safety data in humans is limited due to the scarcity of clinical trials. Potential side effects may include gastrointestinal upset and interactions with medications metabolized by cytochrome P450 enzymes, particularly CYP3A4. Due to its cholinesterase inhibitory activity, palmatine may potentiate the effects of cholinesterase inhibitors and anticholinergic medications. Pregnant and nursing women should avoid palmatine supplementation due to insufficient safety data.